COMMUNIQUÉS West-GlobeNewswire

Ocugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025
02/09/2025
MALVERN, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar [...]
Kraig Biocraft Laboratories' Lead Sericulture Expert Joins Recombinant Spider Silk Production Team at New Rearing Facility in Southeast Asia
02/09/2025
ANN ARBOR, Mich., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced that Dr. Nirmal Kumar, the [...]
Zenas BioPharma and Royalty Pharma Enter into Obexelimab Funding Agreement for up to $300 Million
02/09/2025
- Initial $75 million to fund the potential U.S. commercial launch of obexelimab for the treatment of IgG4-Related Disease - - Additional $150 million associated with the upcoming results of the obexelimab Phase 3 [...]
Alterity Therapeutics to Present at the Biotech Showcase
02/09/2025
MELBOURNE, Australia and SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying [...]
Rezolute Announces Alignment with FDA on Streamlined Design for Ongoing Phase 3 Trial of Ersodetug in Tumor Hyperinsulinism
02/09/2025
Open-label study in as few as 16 tumor hyperinsulinism (HI) patients Study initiated and enrolling patients in the U.S. and Europe Topline data expected in the second half of 2026 REDWOOD CITY, Calif., Sept. 02, 2025 ( [...]
Anavex Life Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference 2025
02/09/2025
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's [...]
MediWound’s NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress
02/09/2025
MediWound’s NexoBrid ® to be Highlighted in 36 Scientific Presentations at the 21 st European Burns Association Congress YAVNE, Israel, September 2, 2025 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next- [...]
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/09/2025
CLEVELAND, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved [...]
Theratechnologies annonce que les agences de conseil en vote indépendantes ISS et Glass Lewis recommandent aux actionnaires de voter « EN FAVEUR » du plan d’arrangement prévu avec Future Pak
02/09/2025
Votre vote est important, quel que soit le nombre d’actions que vous détenez. Le conseil d’administration recommande à l’unanimité aux actionnaires de voter EN FAVEUR de l’arrangement. Les actionnaires sont invités à [...]
Theratechnologies Announces Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Shareholders Vote “FOR” the Proposed Plan of Arrangement with Future Pak
02/09/2025
Your vote is important regardless of the number of Shares you own. Board unanimously recommends shareholders vote “FOR” the Arrangement. Shareholders are encouraged to review the circular carefully and submit their [...]
Avicanna LATAM SAS Teams Up With Harrington Wellness to Launch re+PLAY CBD Wellness Brand Topicals in the United States
02/09/2025
re+PLAY is a CBD wellness brand founded by NBA veteran Al Harrington with products utilizing Avicanna’s patented and proprietary CBD formulations. The initial launch of re+PLAY in the United States includes two products [...]
CorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership Team
02/09/2025
- Transformational deal for CorMedix that expands and diversifies company’s commercial product portfolio, with seven innovative drug products and a pipeline expansion indication with near-term revenue growth potential [...]
BridgeBio to Present Phase 2 Proof-of-Concept Data for Encaleret in Post-Surgical Hypoparathyroidism
02/09/2025
PALO ALTO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that an [...]
Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use
02/09/2025
GAITHERSBURG, Md., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $30 million contract modification from the Biomedical Advanced Research and Development [...]
Stereotaxis to Present at Upcoming Investor Conferences
02/09/2025
ST. LOUIS, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and [...]
Highridge Medical Acquires Innovative Products from Accelus to Expand Capabilities in Spine Surgery
02/09/2025
Deal adds innovative expandable cage and other implant technology to the Highridge portfolio. WESTMINSTER, Colo., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Highridge Medical, one of the world’s largest privately held spine [...]
RAPPEL – La Fondation du Microbiote de Biocodex invite les universitaires et scientifiques canadiens à soumettre leur candidature pour une bourse de recherche de 35 000 €
02/09/2025
L’objectif est de faire progresser l’étude du rôle du microbiote sur la santé et les maladies humaines MONTRÉAL, 02 sept. 2025 (GLOBE NEWSWIRE) -- La Fondation du Microbiote de Biocodex , une organisation fondée par [...]
REMINDER – Biocodex Microbiota Foundation invites Canadian academics and scientists to apply for €35,000 research grant
02/09/2025
The objective is to advance microbiota’s role study in human health & diseases MONTREAL, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The Biocodex Microbiota Foundation , an organization founded by Biocodex and dedicated to [...]
Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
02/09/2025
NORCROSS, Ga., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that the company management will [...]

Pages